Human, financial, and other resources have been and continue to be reallocated from TB treatment and prevention to the COVID-19 response.
Tuberculosis Management in the Time of COVID-19
To Effectively Fight Global Pandemics, We Must Break the “Cycle of Panic and Neglect”
In September of 2019, the World Health Organization (WHO) and Global Preparedness Monitoring Board (GPMB) published a report with a warning—our risk of a global pandemic was on the rise, and the world was not prepared. Three months later, in December 2019, the first COVID-19 cases were reported to the World Health Organization.
Advances in Fighting Infectious Disease in 2020 Include Progress on Tuberculosis & COVID-19
As infectious diseases evolve, the medical community has been working to meet the challenge by updating and improving the tools we use to combat infections. Right now, biopharmaceutical research companies have 421 medicines and vaccines in development to treat or prevent fungal, bacterial, and viral infections.
Decades of Progress Against the World’s Deadliest Diseases Could be Lost to the COVID-19 Pandemic
Three well-established infectious diseases—Tuberculosis, malaria, and HIV—are poised to kill millions worldwide, with decades of healthcare progress that could be lost due to disruptions caused by COVID-19. Even under normal circumstances, the toll these three diseases exact worldwide is staggering.
World Antimicrobial Awareness Week 2020 Toolkit
Each year, healthcare organizations, schools, governments, companies, and communities around...
COVID-19 and Antimicrobial Resistance: Dual Health Threats
Each year, more than 700,000 people lose their lives to...